科学认识生物类似药,推动生物类似药的合理使用和发展——抗肿瘤生物类似药应用重庆专家共识  

To promote the rational use and healthy development of biosimilars through scientific understanding of biosimilars:Chongqing experts consensus on the application of anti-tumor biosimilars

作　　者：单锦露 孙建国 阮志华 任必勇 杨志祥 李毅[6] 田福华 康保国 赵晓辉[9] 刘作金[10] 南映瑜 邓媛[12] 朱宇熹[13] 王东林 陈正堂 王东 SHAN Jinlu;SUN Jianguo;RUAN Zhihua;REN Biyong;YANG Zhixiang;LI Yi;TIAN Fuhua;KANG Baoguo;ZHAO Xiaohui;LIU Zuojin;NAN Yingyu;DENG Yuan;ZHU Yuxi;WANG Donglin;CHEN Zhengtang;WANG dong(Daping Hospital,Army Medical University,Chongqing 400042,China;Xinqiao Hospital,Army Medical University,Chongqing 400037,China;Southwest Hospital,Army Medical University,Chongqing 400038,China;Three Gorges Central Hospital Affiliated to Chongqing University,Chongqing 5001014,China;Chongqing Traditional Chinese Medicine Hospital,Chongqing 400011,China;Beibei Traditional Chinese Medical Hospital,Chongqing 400700,China;People′s Hospital of Jiulongpo District,Chongqing 400050,China;The First People′s Hospital of Chongqing Liang Jiang New Area,Chongqing 401147,China;The Ninth People′s Hospital of Chongqing,Chongqing 400700,China;The Second Affiliated Hospital of Chongqing Medical University,Chongqing 400067,China;Chongqing University Cancer Hospital,Chongqing 400030,China;Chongqing Emergency Medical Center/the Fourth People′s Hospital of Chongqing 400010,China;Jinshan Hospital,the First Affiliated Hospital of Chongqing Medical University,Chongqing 401120,China)

机构地区：[1]中国人民解放军陆军特色医学中心,重庆400042 [2]中国人民解放军陆军军医大学新桥医院,重庆400037 [3]中国人民解放军陆军军医大学西南医院,重庆400038 [4]重庆大学附属三峡医院,重庆500101 [5]重庆市中医院,400011 [6]重庆市北碚区中医院,400700 [7]重庆市九龙坡区人民医院,400050 [8]重庆市两江新区第一人民医院,401147 [9]重庆市第九人民医院,400700 [10]重庆医科大学附属第二医院,400067 [11]重庆大学附属肿瘤医院,400030 [12]重庆市急救医疗中心/重庆市第四人民医院,400010 [13]重庆医科大学附属第一医院金山医院,401120

出　　处：《重庆医学》2020年第22期3685-3687,共3页Chongqing medicine

摘　　要：抗肿瘤生物类似药在肿瘤临床治疗中发挥着重要作用,如何合理应用生物类似药是临床实践必须面对的问题。重庆专家重点探讨了抗肿瘤生物类似药的有效性、安全性、适应证外推及参照药转换问题,对其在临床应用上具有指导意义。Anti-tumor biosimilars are playing an important role in the clinical treatment of tumors.How to reasonably use biosimilars is a problem that must be faced in clinical practice.Discussion of Chongqing experts focused on the effectiveness,safety,indication extrapolation and conversion between anti-tumor biosimilars and reference drugs,which has guiding significance in clinical application.

关 键 词：肿瘤 生物类似药 有效性 安全性 适应证 专家共识 

分 类 号：R979.1[医药卫生—药品]